DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS

被引：0
|
作者：
Oldgren, Jonas
Alings, Marco
Darius, Harald
Eikelboom, John
Ezekowitz, Michael
Parekh, Amit
Pogue, Janice
Reilly, Paul
Yusuf, Salim
Wallentin, Lars
Connolly, Stuart
机构：
[1] Uppsala Clin Res Ctr, Uppsala, Sweden
[2] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0903-04
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Usefulness of the CHADS2 Score for Determining Risk of Seizure in Patients With Atrial Fibrillation
    Hsu, Chien-Yi
    Chen, Tz-Heng
    Su, Yu-Wen
    Chang, Chun-Chin
    Chen, Mu-Hong
    Leu, Hsin-Bang
    Huang, Po-Hsun
    Chen, Jaw-Wen
    Lin, Shing-Jong
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (09): : 1340 - 1344
  • [42] Antithrombotic treatment in elderly patients with atrial fibrillation and CHADS2 score=1
    Fauchier, L.
    Gorin, L.
    Nonin, E.
    Haguenoer, K.
    Charbonnier, B.
    Babuty, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 923 - 923
  • [43] Dabigatran versus Warfarin for stroke prevention in Patients with Atrial Fibrillation: A Post-Hoc Analysis of RE-LY Correlating Body Mass Index with Outcome According to BMI Quintiles
    Jacobs, Mark
    Arce, Javier
    McAndrew, Thomas
    Wallentin, Lars
    Ezekowitz, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B81 - B81
  • [44] Dabigatran versus warfarin in patients with pacemaker or defibrillator wires in the RE-LY trial: the role of contact activation
    Ezekowitz, M. D.
    Parise, H.
    Noack, H.
    Brueckmann, M.
    Clemens, A.
    Connolly, S.
    Reilly, P.
    Yusuf, S.
    Wallentin, L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1115 - 1115
  • [45] Left atrial sphericity improves CHADS2 score stroke prediction in patients with atrial fibrillation
    Bisbal Van Bylen, F.
    Gomez-Pulido, F.
    Akoum, N.
    Calvo, M.
    Cabanas-Grandio, P.
    Vidal, B.
    Brugada, J.
    Marrouche, N. F.
    Mont, L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1104 - 1104
  • [46] Global Left Atrial Strain Correlates with CHADS2 Risk Score in Patients with Atrial Fibrillation
    Saha, Samir K.
    Anderson, Paula L.
    Caracciolo, Giuseppe
    Kiotsekoglou, Anatoli
    Wilansky, Susan
    Govind, Satish
    Mori, Naoyo
    Sengupta, Partho P.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2011, 24 (05) : 506 - 512
  • [47] Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS2 Score without Atrial Fibrillation
    Hasegawa, Yuki
    Hamada, Satomi
    Nishimura, Takuro
    Sasaki, Takeshi
    Ebana, Yusuke
    Kawabata, Mihoko
    Goya, Masahiko
    Isobe, Mitsuaki
    Koyama, Takatoshi
    Furukawa, Tetsushi
    Hirao, Kenzo
    Sasano, Tetsuo
    PLOS ONE, 2016, 11 (06):
  • [48] Letter by Freeman et al Regarding Article, "Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY Trial"
    Freeman, W. David
    Kuo, Ruth
    Aguilar, Maria I.
    STROKE, 2012, 43 (07) : E63 - E63
  • [49] Efficacy and Safety of Dabigatran Compared With Warfarin in Patients With Atrial Fibrillation and Normal Renal Function Over Time: Insights From the RE-LY Trial
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION, 2015, 132
  • [50] CHADS2 score predicts time interval free of atrial fibrillation in patients with symptomatic paroxysmal atrial fibrillation
    Ilic, Ljubomir M.
    Goldenberg, Edward M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (03) : 576 - 577
12345